{"id":"W1971589784","doi":"10.1016/j.bbmt.2009.11.026","title":"Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia Relapsing in Chronic and Advanced Phase Following Allogeneic Hematopoietic Stem Cell Transplantation","year":2009,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Chronic myelogenous leukemia; Dasatinib; Internal medicine; Imatinib; Hematopoietic stem cell transplantation; Tyrosine-kinase inhibitor; Oncology; Transplantation; Nilotinib; Gastroenterology; Leukemia; Odds ratio; Immunology; Cancer; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002242387,0.0002539034,0.0004443634,0.0003170958,0.00005262381,0.000006572404,0.00004665767,0.000170572,0.000003715352],"category_scores_gemma":[0.000003885605,0.0002194309,0.00004262753,0.0002411486,0.00005978491,0.0001135108,0.00000351097,0.0001409811,6.543289e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004580541,"about_ca_system_score_gemma":0.0003860411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006212806,"about_ca_topic_score_gemma":0.0002070124,"domain_scores_codex":[0.9985456,0.0001430507,0.0004299616,0.0004327968,0.0001303309,0.0003182479],"domain_scores_gemma":[0.9995161,0.00009630233,0.0001080477,0.0001474482,0.00002967805,0.0001024708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01680663,0.0004089873,0.05772556,0.0003189807,0.00004921827,0.000185222,0.002311443,0.0000963861,0.8863204,0.000005311502,4.345736e-7,0.03577148],"study_design_scores_gemma":[0.107972,0.02040677,0.4033941,0.001693816,0.0004254996,0.0001134286,0.00009207387,0.00004500674,0.4654278,0.00002538419,0.00001586208,0.0003882786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938703,0.004600043,0.0001368807,0.0001168801,0.00004639622,0.001149786,0.00004309764,0.00002499723,0.00001168254],"genre_scores_gemma":[0.9960449,0.002924918,0.0005888831,0.00008041377,0.00001801606,0.00003791853,0.0002730924,0.00002094732,0.00001095404],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4208926,"threshold_uncertainty_score":0.8948132,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006951639614285477,"score_gpt":0.2426961025469065,"score_spread":0.2357444629326211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}